Holdings Information

Bibliographic Record Display

• Title:[Drug information (Malone)]
  Drug information : a guide for pharmacists / editors, Patrick M. Malone, Karen L. Kier, John E. Stanovich, Meghan J. Malone.
  
•    
• Other Contributors/Collections:Malone, Patrick M., 1954- editor.
  Kier, Karen L., editor.
  Stanovich, John E., editor.
  Malone, Meghan J., editor.
  
• Published/Created:New York : McGraw-Hill, [2014]
  

• Holdings

  Holdings Record Display

  • Location:WOODWARD LIBRARY stacksWhere is this?
    
  • Call Number: QV737.1 .D794 2014
    
  • Number of Items:1
    
  • Status:Available
    

   
• Library of Congress Subjects:Pharmacy--Information services.
  Drugs.
  
• Medical Subjects: Drug Information Services.
  Pharmacy Administration--methods.
  
• Edition:Fifth edition.
  
• Description:xxvi, 1317 pages ; 23 cm
  
• Summary:This trusted guide teaches students and professionals how to research, interpret, evaluate, collate, and disseminate drug information in the most effective and efficient manner possible.
  
• Notes:Includes bibliographical references and index.
  
• ISBN:9780071804349 (soft cover : alk. paper)
  007180434X
  
• Contents:Machine generated contents note: Introduction / J. Russell May / Mary Lea Gora-Harper
  Beginning / J. Russell May / Mary Lea Gora-Harper
  Evolution / J. Russell May / Mary Lea Gora-Harper
  Opportunities in Specialty Practice / J. Russell May / Mary Lea Gora-Harper
  Summary and Direction for the Future / J. Russell May / Mary Lea Gora-Harper
  Self-Assessment Questions / J. Russell May / Mary Lea Gora-Harper
  Introduction / Amy Heck Sheehan / Karim Anton Calis
  Conclusion / Amy Heck Sheehan / Karim Anton Calis
  Case Study 2-1 / Amy Heck Sheehan / Karim Anton Calis
  Case Study 2-2 / Amy Heck Sheehan / Karim Anton Calis
  Case Study 2-3 / Amy Heck Sheehan / Karim Anton Calis
  Case Study 2-4 / Amy Heck Sheehan / Karim Anton Calis
  Self-Assessment Questions / Amy Heck Sheehan / Karim Anton Calis
  Introduction / Elaine Blythe / Kelly M. Shields
  Tertiary Resources / Elaine Blythe / Kelly M. Shields
  Case Study 3-1 / Elaine Blythe / Kelly M. Shields
  Case Study 3-1 / Elaine Blythe / Kelly M. Shields
  Case Study 3-1 / Elaine Blythe / Kelly M. Shields
  Case Study 3-1 / Elaine Blythe / Kelly M. Shields
  Secondary Literature / Elaine Blythe / Kelly M. Shields
  Case Study 3-1 / Elaine Blythe / Kelly M. Shields
  Primary Literature / Elaine Blythe / Kelly M. Shields
  Alternative Resources / Kelly M. Shields / Elaine Blythe
  Case Study 3-1 / Elaine Blythe / Kelly M. Shields
  Consumer Health Information / Elaine Blythe / Kelly M. Shields
  Conclusion / Elaine Blythe / Kelly M. Shields
  Case Study 3-1 / Elaine Blythe / Kelly M. Shields
  Self-Assessment Questions / Elaine Blythe / Kelly M. Shields
  Introduction / Michael G. Kendrach / Peter J. Hughes / Maisha Kelly Freeman
  Biomedical/Pharmacy Literature / Michael G. Kendrach / Peter J. Hughes / Maisha Kelly Freeman
  Approach to Evaluating Research Studies (True Experiments) / Michael G. Kendrach / Peter J. Hughes / Maisha Kelly Freeman
  Case Study 4-1 / Michael G. Kendrach / Peter J. Hughes / Maisha Kelly Freeman
  Conclusion / Michael G. Kendrach / Peter J. Hughes / Maisha Kelly Freeman
  Case Study 4-1 / Michael G. Kendrach / Peter J. Hughes / Maisha Kelly Freeman
  Case Study 4-1 / Michael G. Kendrach / Peter J. Hughes / Maisha Kelly Freeman
  Self-Assessment Questions / Michael G. Kendrach / Peter J. Hughes / Maisha Kelly Freeman
  Introduction / Patrick J. Bryant / Elizabeth A. Van Dyke / Cydney E. McQueen
  Beyond the Basic Controlled Trial / Patrick J. Bryant / Elizabeth A. Van Dyke / Cydney E. McQueen
  Case Study 5-1: Noninferiority Trial Design / Patrick J. Bryant / Elizabeth A. Van Dyke / Cydney E. McQueen
  Case Study 5-2: Noninferiority Trial Design / Patrick J. Bryant / Elizabeth A. Van Dyke / Cydney E. McQueen
  Observational Study Design / Patrick J. Bryant / Elizabeth A. Van Dyke / Cydney E. McQueen
  Case Study 5-3: Cohort Study Design / Patrick J. Bryant / Elizabeth A. Van Dyke / Cydney E. McQueen
  Reports Without Control Group / Patrick J. Bryant / Elizabeth A. Van Dyke / Cydney E. McQueen
  Survey Research / Patrick J. Bryant / Elizabeth A. Van Dyke / Cydney E. McQueen
  Postmarketing Surveillance Studies / Patrick J. Bryant / Elizabeth A. Van Dyke / Cydney E. McQueen
  Review Articles / Elizabeth A. Van Dyke / Cydney E. McQueen / Patrick J. Bryant
  Case Study 5-4: Meta-Analysis / Patrick J. Bryant / Elizabeth A. Van Dyke / Cydney E. McQueen
  Practice Guidelines / Patrick J. Bryant / Elizabeth A. Van Dyke / Cydney E. McQueen
  Health Outcomes Research / Patrick J. Bryant / Elizabeth A. Van Dyke / Cydney E. McQueen
  Dietary Supplement Medical Literature / Patrick J. Bryant / Elizabeth A. Van Dyke / Cydney E. McQueen
  Case Study 5-5: Trials Testing Natural Products / Patrick J. Bryant / Elizabeth A. Van Dyke / Cydney E. McQueen
  Getting to a Clinical Decision / Patrick J. Bryant / Elizabeth A. Van Dyke / Cydney E. McQueen
  Conclusion / Patrick J. Bryant / Elizabeth A. Van Dyke / Cydney E. McQueen
  Self-Assessment Questions / Patrick J. Bryant / Elizabeth A. Van Dyke / Cydney E. McQueen
  Acknowledgments / Patrick J. Bryant / Elizabeth A. Van Dyke / Cydney E. McQueen
  Introduction / Karen L. Rascati / James P. Wilson
  Pharmacoeconomics: What Is It and Why Do It? / Karen L. Rascati / James P. Wilson
  Relationships of Pharmacoeconomics to Outcomes Research / Karen L. Rascati / James P. Wilson
  Models of Pharmacoeconomic Analysis / Karen L. Rascati / James P. Wilson
  Assessment of Costs / Karen L. Rascati / James P. Wilson
  Assessment of Outcomes / Karen L. Rascati / James P. Wilson
  Performing an Economic Analysis / Karen L. Rascati / James P. Wilson
  What Is Decision Analysis? / Karen L. Rascati / James P. Wilson
  Steps in Reviewing Published Literature / Karen L. Rascati / James P. Wilson
  Case Study 6-1 / Karen L. Rascati / James P. Wilson
  Selected Pharmacoeconomic Web Sites / Karen L. Rascati / James P. Wilson
  Conclusion / Karen L. Rascati / James P. Wilson
  Self-Assessment Questions / Karen L. Rascati / James P. Wilson
  Introduction / Vicki R. Kee / Kevin G. Moores
  Evidence-Based Medicine and Clinical Practice Guidelines / Vicki R. Kee / Kevin G. Moores
  Guideline Development Methods / Vicki R. Kee / Kevin G. Moores
  Case Study 7-1 / Vicki R. Kee / Kevin G. Moores
  Case Study 7-1 / Vicki R. Kee / Kevin G. Moores
  Case Study 7-1 / Vicki R. Kee / Kevin G. Moores
  Guideline Evaluation Tools / Vicki R. Kee / Kevin G. Moores
  Implementation of Clinical Practice Guidelines / Vicki R. Kee / Kevin G. Moores
  Case Study 7-1 / Vicki R. Kee / Kevin G. Moores
  Sources of Clinical Practice Guidelines / Vicki R. Kee / Kevin G. Moores
  Conclusion / Vicki R. Kee / Kevin G. Moores
  Self-Assessment Questions / Vicki R. Kee / Kevin G. Moores
  Introduction / Ryan W. Walters
  Populations and Sampling / Ryan W. Walters
  Variables and the Measurement of Data / Ryan W. Walters
  Descriptive Statistics / Ryan W. Walters
  Common Probability Distributions / Ryan W. Walters
  Epidemiological Statistics / Ryan W. Walters
  Types of Study Design / Ryan W. Walters
  Case Study 8-1 / Ryan W. Walters
  Design and Analysis of Clinical Trials / Ryan W. Walters
  Statistical Inference / Ryan W. Walters
  Selecting the Appropriate Statistical Test / Ryan W. Walters
  Case Study 8-1 / Ryan W. Walters
  Statistical Tests / Ryan W. Walters
  Conclusion / Ryan W. Walters
  Self-Assessment Questions / Ryan W. Walters
  Introduction / Patrick M. Malone / Meghan J. Malone
  Steps in Writing / Patrick M. Malone / Meghan J. Malone
  Case Study 9-1 / Patrick M. Malone / Meghan J. Malone
  Specific Documents / Patrick M. Malone / Meghan J. Malone
  Case Study 9-2 / Patrick M. Malone / Meghan J. Malone
  Case Study 9-3 / Patrick M. Malone / Meghan J. Malone
  Conclusion / Patrick M. Malone / Meghan J. Malone
  Self-Assessment Questions / Patrick M. Malone / Meghan J. Malone
  Introduction / Martha M. Rumore
  Tort Law / Martha M. Rumore
  Case Study 10-1 / Martha M. Rumore
  Case Study 10-1 / Martha M. Rumore
  Defenses to Negligence and Malpractice Protection / Martha M. Rumore
  Labeling and Advertising / Martha M. Rumore
  Liability Concerns for Web 2.0 Information / Martha M. Rumore
  Intellectual Property Rights / Martha M. Rumore
  Case Study 10-3 / Martha M. Rumore
  Privacy / Martha M. Rumore
  Case Study 10-4 / Martha M. Rumore
  Industry Support for Educational Activities / Martha M. Rumore
  Conclusion / Martha M. Rumore
  Self-Assessment Questions / Martha M. Rumore
  What Is Ethics and What Is Not / Linda K. Ohri
  Ethical Dilemmas When Providing Drug Information / Linda K. Ohri
  Basics of Ethics Analysis / Linda K. Ohri
  Example Case 11-1 / Linda K. Ohri
  Example Case 11-1 / Linda K. Ohri
  Case Study 11-1 / Linda K. Ohri
  Case Study 11-1 / Linda K. Ohri
  Resources for Use by Professionals Seeking to Learn More about Medical Ethics, as Applied to Issues Involving Provision of Drug Information / Linda K. Ohri
  Structures That Support Ethical Decision Making / Linda K. Ohri
  Conclusion / Linda K. Ohri
  Self-Assessment Questions / Linda K. Ohri
  Introduction / Patrick M. Malone / Nancy L. Fagan / Mark A. Malesker / Paul J. Nelson
  Organizational Background / Patrick M. Malone / Nancy L. Fagan / Mark A. Malesker / Paul J. Nelson
  Pharmacy Support of the P&T Committee / Patrick M. Malone / Nancy L. Fagan / Mark A. Malesker / Paul J. Nelson
  Case Study 12-1 / Patrick M. Malone / Nancy L. Fagan / Mark A. Malesker / Paul J. Nelson
  Case Study 12-1 / Patrick M. Malone / Nancy L. Fagan / Mark A. Malesker / Paul J. Nelson
  Clinical Guidelines / Patrick M. Malone / Nancy L. Fagan / Mark A. Malesker / Paul J. Nelson
  Standard Order Set Development / Patrick M. Malone / Nancy L. Fagan / Mark A. Malesker / Paul J. Nelson
  Credentialing and Privileges / Patrick M. Malone / Nancy L. Fagan / Mark A. Malesker / Paul J. Nelson
  Quality Improvement Within the P&T Committee-Internal Audit / Patrick M. Malone / Nancy L. Fagan / Mark A. Malesker / Paul J. Nelson
  Case Study 12-1 / Mark A. Malesker / Nancy L. Fagan / Patrick M. Malone / Paul J. Nelson
  Communication Within an Organization / Paul J. Nelson / Mark A. Malesker / Patrick M. Malone / Nancy L. Fagan
  Contents note continued: Conclusion / Nancy L. Fagan / Paul J. Nelson / Mark A. Malesker / Patrick M. Malone
  Discussion Questions / Mark A. Malesker / Paul J. Nelson / Nancy L. Fagan / Patrick M. Malone
  Self-Assessment Questions / Paul J. Nelson / Mark A. Malesker / Nancy L. Fagan / Patrick M. Malone
  Acknowledgment / Patrick M. Malone / Nancy L. Fagan / Mark A. Malesker / Paul J. Nelson
  Introduction / Nancy L. Fagan / Paul J. Nelson / Mark A. Malesker / Patrick M. Malone
  Drug Evaluation Monograph Sections / Patrick M. Malone / Paul J. Nelson / Nancy L. Fagan / Mark A. Malesker
  Conclusion / Paul J. Nelson / Patrick M. Malone / Nancy L. Fagan / Mark A. Malesker
  Case Study 13-1 / Patrick M. Malone / Nancy L. Fagan / Paul J. Nelson / Mark A. Malesker
  Case Study 13-1 / Patrick M. Malone / Nancy L. Fagan / Mark A. Malesker / Paul J. Nelson
  Self-Assessment Questions / Patrick M. Malone / Nancy L. Fagan / Mark A. Malesker / Paul J. Nelson
  Acknowledgments / Patrick M. Malone / Paul J. Nelson / Mark A. Malesker / Nancy L. Fagan
  Introduction / David P. Nau
  Changing Environment for Health Care Quality / David P. Nau
  Purpose of Measuring Quality / David P. Nau
  Quality Improvement / David P. Nau
  Case Study 14-1 / David P. Nau
  Case Study 14-1 / David P. Nau
  Case Study 14-1 / David P. Nau
  Quality in Drug Information / David P. Nau
  Conclusion / David P. Nau
  Self-Assessment Questions / David P. Nau
  Introduction to Adverse Drug Reactions / Zara Risoldi Cochrane / Darren Hein / Philip J. Gregory
  Causality and Probability of Adverse Drug Reactions / Philip J. Gregory / Darren Hein / Zara Risoldi Cochrane
  Case Study 15-1 / Zara Risoldi Cochrane / Darren Hein / Philip J. Gregory
  Classification of Adverse Drug Reactions / Zara Risoldi Cochrane / Philip J. Gregory / Darren Hein
  Implementing a Program / Philip J. Gregory / Darren Hein / Zara Risoldi Cochrane
  Reporting Adverse Drug Reactions / Darren Hein / Philip J. Gregory / Zara Risoldi Cochrane
  Case Study 15-1 / Philip J. Gregory / Darren Hein / Zara Risoldi Cochrane
  Future Approaches to Pharmacovigilance / Zara Risoldi Cochrane / Philip J. Gregory / Darren Hein
  Conclusion / Darren Hein / Philip J. Gregory / Zara Risoldi Cochrane
  Self-Assessment Questions / Philip J. Gregory / Darren Hein / Zara Risoldi Cochrane
  Introduction / Kathryn A. Crea
  Definitions: Medication Errors, Adverse Drug Events, and Adverse Drug Reactions / Kathryn A. Crea
  Impact of Errors on Patients and Health Care Systems / Kathryn A. Crea
  Identification and Reporting of Medication Errors and Adverse Drug Events / Kathryn A. Crea
  Classification of Error Types / Kathryn A. Crea
  Classifying Patient Outcomes / Kathryn A. Crea
  National Reporting / Kathryn A. Crea
  Managing an Event Reporting System / Kathryn A. Crea
  Types of Safety Event Analysis / Kathryn A. Crea
  Case Study 16-1 / Kathryn A. Crea
  To Err Is Human / Kathryn A. Crea
  System Error / Kathryn A. Crea
  Case Study 16-1 / Kathryn A. Crea
  Just Culture-Not Shame and Blame / Kathryn A. Crea
  Case Study 16-1 / Kathryn A. Crea
  Risk Factors for Errors and Events / Kathryn A. Crea
  Health Professions Education / Kathryn A. Crea
  Best Practices for Error Prevention / Kathryn A. Crea
  Other Principles of Error Management / Kathryn A. Crea
  Putting It All Together / Kathryn A. Crea
  Case Study 16-1 / Kathryn A. Crea
  Conclusion: Safety as a Priority / Kathryn A. Crea
  Self-Assessment Questions / Kathryn A. Crea
  Introduction / Bambi Grilley
  Definitions / Bambi Grilley
  History of Drug Development Regulation in the United States / Bambi Grilley
  Drug Approval Process / Bambi Grilley
  Case Study 17-1 / Bambi Grilley
  Case Study 17-1 / Bambi Grilley
  Orphan Drug Act / Bambi Grilley
  Institutional Review Board / Bambi Grilley
  Case Study 17-1 / Bambi Grilley
  Role of the Health Care Professional / Bambi Grilley
  Conclusion / Bambi Grilley
  Self-Assessment Questions / Bambi Grilley
  Introduction / Sabrina W. Cole / Stacie Krick Evans
  Policy Development / Sabrina W. Cole / Stacie Krick Evans
  Project Design / Sabrina W. Cole / Stacie Krick Evans
  Project Implementation / Sabrina W. Cole / Stacie Krick Evans
  Project Closeout / Sabrina W. Cole / Stacie Krick Evans
  Project Management / Sabrina W. Cole / Stacie Krick Evans
  Conclusion / Sabrina W. Cole / Stacie Krick Evans
  Case Study 18-1 / Sabrina W. Cole / Stacie Krick Evans
  Self-Assessment Questions / Sabrina W. Cole / Stacie Krick Evans
  Introduction / Debra L. Parker
  Why Focus on Drug Information Specifically in the Ambulatory Care Setting? / Debra L. Parker
  Providing Drug Information in the Ambulatory Setting / Debra L. Parker
  Drug Information Responsibilities in Ambulatory Care / Debra L. Parker
  Case Study 19-1 / Debra L. Parker
  Patient Disposal of Unused Medications / Debra L. Parker
  Case Study 19-1 / Debra L. Parker
  Providing Immunization Information / Debra L. Parker
  Quality-Assurance Considerations in Ambulatory Care / Debra L. Parker
  Case Study 19-1 / Debra L. Parker
  Conclusion / Debra L. Parker
  Self-Assessment Questions / Debra L. Parker
  Introduction / Heather A. Pace / Morgan L. Sperry
  Pharmacists as Drug Information Providers in the Community Setting / Heather A. Pace / Morgan L. Sperry
  Current Patient Sources of Drug Information / Heather A. Pace / Morgan L. Sperry
  Case Study 20-1 / Heather A. Pace / Morgan L. Sperry
  Case Study 20-1 / Heather A. Pace / Morgan L. Sperry
  Case Study 20-1 / Heather A. Pace / Morgan L. Sperry
  New Model of Drug Information in the Community Pharmacy / Morgan L. Sperry / Heather A. Pace
  Conclusion / Heather A. Pace / Morgan L. Sperry
  Self-Assessment Questions / Heather A. Pace / Morgan L. Sperry
  Introduction / Michelle W. McCarthy
  Foundation Skill Development / Michelle W. McCarthy
  Specialized Skill Development / Michelle W. McCarthy
  Pursuing Specialty Training / Michelle W. McCarthy
  Case Study 21-1 / Michelle W. McCarthy
  Conclusion / Michelle W. McCarthy
  Self-Assessment Questions / Michelle W. McCarthy
  Acknowledgments / Michelle W. McCarthy
  Introduction / Lindsay E. Davison / Jean E. Cunningham
  Opportunities for Health Professionals Within Industry / Lindsay E. Davison / Jean E. Cunningham
  Regulation of Health Professionals in Industry / Lindsay E. Davison / Jean E. Cunningham
  Case Study 22-1 / Lindsay E. Davison / Jean E. Cunningham
  Pharmaceutical Research and Manufacturers of America and the Code on Interactions with Health Care Professionals / Lindsay E. Davison / Jean E. Cunningham
  Case Study 22-1 / Lindsay E. Davison / Jean E. Cunningham
  Fulfillment of Medical Information Requests / Lindsay E. Davison / Jean E. Cunningham
  Case Study 22-1 / Lindsay E. Davison / Jean E. Cunningham
  Adverse Event Reporting / Lindsay E. Davison / Jean E. Cunningham
  Case Study 22-1 / Lindsay E. Davison / Jean E. Cunningham
  Staying Connected with the Pharmaceutical Industry / Lindsay E. Davison / Jean E. Cunningham
  Anatomy of Federal Agencies / Lindsay E. Davison / Jean E. Cunningham
  Case Study 22-1 / Lindsay E. Davison / Jean E. Cunningham
  Case Study 22-1 / Lindsay E. Davison / Jean E. Cunningham
  Division of Drug Information at the FDA / Lindsay E. Davison / Jean E. Cunningham
  Case Study 22-1 / Lindsay E. Davison / Jean E. Cunningham
  Opportunities Within FDA / Lindsay E. Davison / Jean E. Cunningham
  Conclusion / Lindsay E. Davison / Jean E. Cunningham
  Self-Assessment Questions / Jean E. Cunningham / Lindsay E. Davison
  Introduction / Genevieve Lynn Ness / Robert D. Beckett
  WHO Ethical Criteria for Medicinal Drug Promotion / Genevieve Lynn Ness / Robert D. Beckett
  Direct-to-Consumer Advertising / Genevieve Lynn Ness / Robert D. Beckett
  Case Study 23-1 / Genevieve Lynn Ness / Robert D. Beckett
  Promotions to Health Care Professionals / Genevieve Lynn Ness / Robert D. Beckett
  Case Study 23-1 / Genevieve Lynn Ness / Robert D. Beckett
  Case Study 23-1 / Genevieve Lynn Ness / Robert D. Beckett
  Case Study 23-1 / Genevieve Lynn Ness / Robert D. Beckett
  Conclusion / Genevieve Lynn Ness / Robert D. Beckett
  Self-Assessment Questions / Genevieve Lynn Ness / Robert D. Beckett
  Introduction / Brent I. Fox / Joshua C. Hollingsworth
  Medication Use Process / Joshua C. Hollingsworth / Brent I. Fox
  Pharmacy Informatics / Brent I. Fox / Joshua C. Hollingsworth
  Order entry / Brent I. Fox / Joshua C. Hollingsworth
  Transcription / Brent I. Fox / Joshua C. Hollingsworth
  Dispensing / Brent I. Fox / Joshua C. Hollingsworth
  Administration / Brent I. Fox / Joshua C. Hollingsworth
  Monitoring / Brent I. Fox / Joshua C. Hollingsworth
  Case Study 24-1 / Brent I. Fox / Joshua C. Hollingsworth
  Future: Informatics in the U.S. Health Care System / Brent I. Fox / Joshua C. Hollingsworth
  Case Study 24-1 / Brent I. Fox / Joshua C. Hollingsworth
  Interoperable Electronic Health Records / Brent I. Fox / Joshua C. Hollingsworth
  Case Study 24-1 / Brent I. Fox / Joshua C. Hollingsworth
  Greater Emphasis on Security, Privacy, and Confidentiality of Protected Health Information / Brent I. Fox / Joshua C. Hollingsworth
  Conclusion / Brent I. Fox / Joshua C. Hollingsworth
  Contents note continued: Self-Assessment Questions / Brent I. Fox / Joshua C. Hollingsworth.